Kei Sakamoto

@keisakamoto.bsky.social

Professor Univ. of Copenhagen, Vice Director Novo Nordisk Foundation Center for Basic Metabolic Research, Metabolic Signaling, glucose metabolism, AMPK

The structure of BAY-3827 with wild-type AMPK α2 kinase domain by @zeqiraj.bsky.social & postdoc Mohd. Syed Ayengar helped determine the mechanism of action of this compound and the limitations for its use, addressing a long-standing challenge in the field: the absence of specific AMPK inhibitors.

Bild

Latest publication from the lab spearheaded by @shoreseashell.bsky.social & in collaboration with @zeqiraj.bsky.social is out. Using structural, biochemical & computational tools, this work sheds light on the mechanism of action of BAY-3827 in inhibiting #AMPK 1/3 www.science.org/doi/full/10....

Mechanism and cellular actions of the potent AMPK inhibitor BAY-3827

The mechanism and unique molecular/cellular features of the potent and selective AMPK inhibitor BAY-3827 are unraveled.

science.org

Obesity is a global public health concern closely linked to cardiometabolic complications. This Comment provides views on recent breakthroughs, emerging innovations and future needs of therapeutic interventions to counteract obesity and its associated health risks. www.nature.com/articles/s42...

Shaping the future of cardiometabolic innovation: advances and opportunities - Nature Metabolism

Obesity is a global public health concern closely linked to cardiometabolic complications. This Comment provides our views on recent breakthroughs, emerging innovations and future needs of therapeutic...

nature.com

The surprising result for a GLP-1 pill (orforglipron) is the magnitude of weight loss in a Phase 3 trial of participants with Type 2 diabetes. For still unexplained reasons, people with diabetes lose much less weight on GLP-1 drugs than those with obesity, w/o diabetes.

Bild

Eli Lilly announced positive results from a large clinical trial of its once-daily pill orforglipron in people with type 2 diabetes, while Pfizer announced last week it was halting development of its candidate after signs of liver injury in a trial participant.

BildBild

President Donald Trump has nominated Susan Monarez, an infectious disease researcher and current acting director of the Centers for Disease Control and Prevention, to become the agency’s permanent leader. scim.ag/425J0xs

Trump’s new CDC pick ‘has her work cut out for her’

Susan Monarez, an expert in biosecurity and infectious disease, strikes some as a sensible choice to head the health agency—but some staffers there have raised concerns

scim.ag

Interested in aging? Super excited about this upcoming Keystone meeting!! 🧪🌲🌲 Aging: Immune Function and Organ Health -- Banff, Canada in 2026!!! ✨✨ Joint meeting with the Keystone Innate Immunity meeting! #aging #immunity @keystonesymposia.bsky.social www.keystonesymposia.org/conferences/...

Aging: Immune Function and Organ Health | Keystone Symposia

Join us at the Keystone Symposia on Aging: Immune Function and Organ Health, March 2026, in Banff, with field leaders!

keystonesymposia.org

Thank you very much for this initiative and providing us with the opportunity to share our memories and stories. His legacy will stay forever. Visionary and inspirational leader, researcher and generous mentor and friend.

IRB Barcelona@irbbarcelona.org · last yr.

Honoring Dr. Joan Guinovart—a visionary in science and an inspiration to many. Share your memories, stories, and gratitude to celebrate his remarkable legacy. Let’s keep his spirit alive: ➡️ www.irbbarcelona.org/en/guinovart

"The academic structure … makes planning for a family feel like an impossible luxury." In this #ScienceWorkingLife, two postdocs share how, as women in academia, having children can feel impossible—and how talking about it makes them feel less alone. scim.ag/3F60VMt #InternationalWomensDay

As women in academia, having children can feel impossible. Talking about it makes us feel less alone

The struggle is “balancing their careers not just with motherhood, but with what comes before: relationships and planning for a family,” these postdocs write

scim.ag

Pleased to share our new preprint describing mechanistic insights and cellular selectivity of the AMPK inhibitor.

BildBild
Sakamoto Lab@labsakamoto.bsky.social · last yr.

New pre-print from the lab @cbmr.science spearheaded by PhD student, Conchita Bringas & in collaboration with @zeqiraj.bsky.social @universityofleeds.bsky.social; providing structure-based molecular insights & cellular actions of the recently identified potent #AMPK inhibitor, BAY-3827.